百合医疗Baihe品牌怎么样 申请店铺

我要投票 百合医疗Baihe在医疗器械行业中的票数:316 更新时间:2025-06-30
百合医疗Baihe是哪个国家的品牌?「百合医疗Baihe」是 广东百合医疗科技股份有限公司 旗下著名品牌。该品牌发源于广东省佛山市,由创始人黄 *在1999年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力百合医疗Baihe品牌出海!将品牌入驻外推网,定制百合医疗Baihe品牌推广信息,可以显著提高百合医疗Baihe产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

百合医疗Baihe怎么样

广东百合医疗科技股份有限公司,创办于1999年,位于佛山市南海区狮山镇桃园东路89号。公司主营业务为一次性使用医用耗材等医疗器械的研发、生产和销售,是一家现代工程技术和临床医学相结合的企业,是国内高端医用耗材领域能够与国外产品形成强有力竞争的为数不多的企业之一。

公司拥有国内先进的医用耗材生产工艺和技术,完善的质量保证体系,现代化的管理手段以及高品质的产品和优质的服务。从公司创立之初的中心静脉导管和血液透析导管起步,截止目前,公司已经形成静脉输液耗材、血液净化耗材、护创敷料耗材三大领域,并依托三大领域的技术优势和丰富的产品储备,成为上述领域内的一次性使用医用耗材综合解决方案提供商。

公司聚集了由陈建华等医用耗材专家领衔的高水平专业研发和技术创新团队,人才储备充足,专业涵盖医用高分子材料、生物医学工程、临床医学、检验医学、生命科学、生物化学、材料学、模具、机械等多个学科。公司主要产品有:中心静脉导管、血液透析导管、输液接头、延长管、旋塞、留置针、血液回路、内瘘穿刺包、压力传感器等三类医疗器械。

产品已经销往世界各地,其中中心静脉导管及血液透析导管两个主导产品国内市场占有率均较高。

公司获得包括华南理工大学、暨南大学、中山大学附属医院、南方医科大学珠江医院等院校及各级政府机构和社会各界的关注和支持,使得百合医疗对医用导管产品的基础研究和临床试用得以顺利开展,并取得长足进步。

公司将继续秉承“注重信誉,对生命负责;追求卓越,让顾客满意”的价值观,坚持以“用户为中心”的设计理念,继续致力于一次性使用医用耗材等医疗器械的研发、生产和销售。公司将本着“为患者负责”的精神,精益求精,争取早日跻身世界领先的一次性使用医用耗材综合解决方案提供商行列。


Guangdong Baihe Medical Technology Co., Ltd., founded in 1999, is located at No. 89, Taoyuan East Road, Shishan town, Nanhai District, Foshan City. The main business of the company is the research and development, production and sales of disposable medical consumables and other medical devices. It is an enterprise combining modern engineering technology and clinical medicine, and one of the few enterprises in the domestic high-end medical consumables field that can form strong competition with foreign products. The company has advanced production technology and technology of medical consumables, perfect quality assurance system, modern management means, high-quality products and high-quality services. From the beginning of the company's establishment, the central venous catheter and hemodialysis catheter started. Up to now, the company has formed three major fields: intravenous infusion consumables, blood purification consumables and nursing wound dressing consumables. Relying on the technical advantages and rich product reserves of the three fields, the company has become a comprehensive solution provider of disposable medical consumables in the above fields. The company has gathered a high-level professional R & D and technical innovation team led by Chen Jianhua and other medical consumables experts, with sufficient talent reserve, covering medical polymer materials, biomedical engineering, clinical medicine, laboratory medicine, life science, biochemistry, materials science, mold, machinery and other disciplines. The company's main products are: central venous catheter, hemodialysis catheter, infusion connector, extension tube, cock, indwelling needle, blood circuit, internal fistula puncture bag, pressure sensor and other three types of medical devices. The products have been sold all over the world, and the two leading products of central venous catheter and hemodialysis catheter have a high market share in China. The company has obtained the attention and support from colleges and universities including South China University of technology, Jinan University, Affiliated Hospital of Sun Yat sen University, Pearl River Hospital of Southern Medical University, as well as government agencies at all levels and all sectors of the society, which makes Lily medical carry out the basic research and clinical trial of medical catheter products smoothly and make great progress. The company will continue to adhere to the values of "pay attention to reputation, be responsible for life; pursue excellence, make customers satisfied", adhere to the design concept of "user centered", and continue to be committed to the research, development, production and sales of disposable medical consumables and other medical devices. In the spirit of "being responsible for patients", the company will strive for perfection and become one of the world's leading providers of comprehensive solutions for disposable medical consumables as soon as possible.

本文链接: https://brand.waitui.com/c48592003.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

华为近期一项语音助手相关专利公布

36氪获悉,6月29日,余承东透露华为Pura80系列将在8月上线“AI超级智能体”。爱企查App显示,华为技术有限公司已申请注册多枚“小艺小艺”商标,国际分类涉及科学仪器、广告销售、餐饮住宿等,目前上述商标多数已注册成功。此外,2025年5月,该公司一项名为“语音助手交互的方法和电子设备”的发明专利公布,该专利所述的电子设备可以根据自身的设备姿态和设备动作来确定是否唤醒语音助手,其中该设备姿态可以是结合电子设备的多种传感器的测量数据确定的。

2小时前

港车北上政策两周年,出入境车辆超285万辆次

“港车北上”政策自2023年7月1日落地实施以来,带动粤港澳大湾区互联互通与融合发展进一步提速。据港珠澳大桥边检站数据显示,截至今年6月30日,完成“港车北上”边检备案车辆已超过10.8万辆次、备案司机超12.9万人次,经该边检站查验的出入境“港车北上”数量已超过285万辆次。(大湾区之声)

2小时前

雷军:小米YU7锁单远超预期,将于7月2日晚8点做一场直播

36氪获悉,小米集团董事长雷军发文称,小米YU7发布以来,媒体和用户朋友们在试驾后给出了很多好评,锁单也远超预期,将于7月2日晚8点做一场直播,集中回答大家关心的一些问题。

2小时前

半日主力资金加仓国防军工股,抛售非银金融股

主力资金早间净流入国防军工、传媒、电子等板块,净流出非银金融、银行、有色金属等板块。具体到个股来看,成飞集成、大东南、东信和平获净流入10.73亿元、8.88亿元、8.47亿元。净流出方面,平安银行、比亚迪、台基股份遭抛售3.13亿元、2.72亿元、2.62亿元。(第一财经)

2小时前

英诺赛科最大基石投资者承诺延长限售

6月30日,氮化镓功率半导体企业英诺赛科发布公告,其最大基石投资者意法半导体(STM)原禁售期于6月29日到期后,已书面承诺未来12个月内不减持任何股份。意法半导体目前持有英诺赛科12592100股H股,占已发行H股总数约2.56%,占当前可流通H股总数约27%。这一承诺彰显了对英诺赛科长期发展的坚定信心。此外,近期,财通证券、招银国际、中信里昂、广发证券、华创证券、国金证券等多家券商发布研报,一致给予积极评级。

2小时前

本页详细列出关于百合医疗Baihe的品牌信息,含品牌所属公司介绍,百合医疗Baihe所处行业的品牌地位及优势。
咨询